Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An instructive case suggesting warfarin resistance which is independent on the regulation of the CYP2C9 and VKORC1 genotype.

Rinsho byori. The Japanese journal of clinical pathology - 1 Dec 2011

Nishimura Fumitaka, Tokuda Masahiro, Sasaki Daisuke, Mori Sayaka, Tsuruda Kazuto, Hasegawa Hiroo, Yanagihara Katsunori, Kamihira Shimeru

Abstract excerpt

To improve the safety and effectiveness of warfarin (WF) therapy, the initial dose trends to be practically decided based on single nucleotide polymorphism (SNP) genotyping of two genes, cytochrome P450 (CYP) 2C9 and vitamin K epoxide reductase complex1 (VKORC1). We encountered a 43-year-old fema...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to International Normalized Ratio

Share to Intracranial Thrombosis

Share to Mixed Function Oxygenases

Share to Seizures

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 22338910

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22338910-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An instructive case suggesting warfarin resistance which is independent on the regulation of the CYP2C9 and VKORC1 genotype.PMID 22338910Read ↗

VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.Semantic proximity Read ↗

Case report: dose adjustment of warfarin using genetic information and plasma concentration monitoring.Semantic proximity Read ↗

Increased frequency of CYP2C9 variant alleles and homozygous VKORC1*2B carriers in warfarin-treated patients with excessive INR response.Semantic proximity Read ↗

Warfarin therapy--why one dose does not fit all!Semantic proximity Read ↗

Anticoagulant therapy for a patient with recurrent pulmonary embolism and warfarin resistance：a case report and literature reviewSemantic proximity Read ↗

A Chinese patient with cardiogenic stroke and warfarin resistance: A case reportSemantic proximity Read ↗

A mysterious resistance to acenocoumarol!Semantic proximity Read ↗

Extremely elevated international normalized ratio of warfarin in a patient with CYP2C9*1/*3 and thyrotoxicosis.Semantic proximity Read ↗

Major bleeding caused by warfarin in a genetically susceptible patient.Semantic proximity Read ↗

Low dose requirement for warfarin treatment in a patient with CYP2C9*3/*13 genotype.Semantic proximity Read ↗

Repeated bleeding complications during therapy with vitamin K antagonists in a patient with the VKORC1*2A and the CYP2C9*3/*3 alleles: genetic testing to support switching to new oral anticoagulants.Semantic proximity Read ↗

Investigating unexpected INRs: in search of the culprit--adherence, interactions, genetics, and superwarfarin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.